Avadel AVDL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Avadel AVDL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (8)	4/9/2003 11:40:34 AM
From: jmanvegas	Read Replies (1) of 240

With several other "important" indications in pre-clinical stage, we'll be seeing additional news throughout the year. Glaxo - BVF - these are major players in bringing stuff to market. It's not as if FLML has to discover new drugs. They just have to take existing drugs or indications already approved, and reformulate them into various dosing needs using proprietary nano-technology. And the diabetes indication could be blockbuster. Looks like sell on the news today, but this is only the beginning over the next several years of additional pharma relationships and commercialization of FLML technology-oriented products. Good luck as always Texas. jman

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next